Concepedia

Author

Yonghua Jing

Bristol-Myers Squibb (United States)

Also Known As

Yonghua Jing

67

Publications

1.2K

Citations

18

H-Index

36

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Bristol-Myers Squibb (Germany)Otsuka (United States)Massachusetts General HospitalPfizer (United States)
YJ

About

Yonghua Jing is an author at Bristol-Myers Squibb (United States) specializing in medicine, psychiatry, and depression.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

127

2

Public Health

2

2

118

3

Social Sciences

2

2

22

4

Epidemiology

1

1

39

5

Family Medicine

1

1

33

Yonghua Jing

×

27

Publications

970

Citations

17

H-Index

YearCitations

Cost burden of treatment resistance in patients with depression.

Teresa B. Gibson, Yonghua Jing, Ginger Smith Carls,

PubMed

2010

159

Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study

Edward Burn, Seng Chan You, Anthony G. Sena,

Nature Communications

2020

107

Medical cost reductions associated with the usage of novel oral anticoagulants vs warfarin among atrial fibrillation patients, based on the RE-LY, ROCKET-AF, and ARISTOTLE trials

Steve Deitelzweig, Alpesh Amin, Yonghua Jing,

Journal of Medical Economics

2012

89

Utilization, price, and spending trends for antidepressants in the US Medicaid program

Yan Chen, Christina M.L. Kelton, Yonghua Jing,

Research in Social and Administrative Pharmacy

2008

79

CLINICAL OUTCOMES IN MEASUREMENT-BASED TREATMENT (COMET): A TRIAL OF DEPRESSION MONITORING AND FEEDBACK TO PRIMARY CARE PHYSICIANS

Albert Yeung, Yonghua Jing, Susan K. Brenneman,

Depression and Anxiety

2012

75

Deep phenotyping of 34,128 patients hospitalised with COVID-19 and a comparison with 81,596 influenza patients in America, Europe and Asia: an international network study

Edward Burn, Seng Chan You, Anthony G. Sena,

2020

48

Warfarin Use and Stroke Risk Among Patients With Nonvalvular Atrial Fibrillation in a Large Managed Care Population

Steven Deitelzweig, Erin Buysman, Brett Pinsky,

Clinical Therapeutics

2013

39

Exposure to Potentially Dangerous Drug-Drug Interactions Involving Antipsychotics

Jeff J. Guo, Jasmanda Wu, Christina M.L. Kelton,

Psychiatric Services

2012

39

Effect of communicating depression severity on physician prescribing patterns: findings from the Clinical Outcomes in MEasurement-based Treatment (COMET) trial

Trina Chang, Yonghua Jing, Albert Yeung,

General Hospital Psychiatry

2012

33

Evaluation of Adherence and Persistence Differences Between Adalimumab Citrate-Free and Citrate Formulations for Patients with Immune-Mediated Diseases in the United States

Martin Bergman, Pankaj Patel, Naijun Chen,

Rheumatology and Therapy

2020

33

Page 1